Advertisement
Advertisement
Why Is Minerva Neurosciences Stock (NERV) Up 165% Today?
PremiumMarket NewsWhy Is Minerva Neurosciences Stock (NERV) Up 165% Today?
24d ago
Minerva announces financing of up to $200M to advance roluperidone
Premium
The Fly
Minerva announces financing of up to $200M to advance roluperidone
24d ago
Minerva Neurosciences Reports Q2 2025 Financial Results
Premium
Company Announcements
Minerva Neurosciences Reports Q2 2025 Financial Results
3M ago
Minerva Neurosciences Reports Improved 2024 Financials
PremiumCompany AnnouncementsMinerva Neurosciences Reports Improved 2024 Financials
8M ago
Hold Rating for Minerva Neurosciences Amidst Uncertainty Over Roluperidone and Financial Constraints
Premium
Ratings
Hold Rating for Minerva Neurosciences Amidst Uncertainty Over Roluperidone and Financial Constraints
9M ago
Minerva reports Q4 EPS (56c) vs. ($1.19) last year
Premium
The Fly
Minerva reports Q4 EPS (56c) vs. ($1.19) last year
9M ago
Minerva reports Q EPS ($1.09) vs ($1.12 ) last year
PremiumThe FlyMinerva reports Q EPS ($1.09) vs ($1.12 ) last year
1y ago
NERV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
NERV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago
Minerva Neurosciences Announces Board and Audit Committee Changes
Premium
Company Announcements
Minerva Neurosciences Announces Board and Audit Committee Changes
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100